Design of nanomaterials for enhanced cancer immunotherapy:A reviewOA
Nanomaterials for precise tumor targeting have entered the era of intelligent medicine,where their versatile applications are being widely studied.In the field of tumor treatment,nanomaterial-based immunotherapy is a highly promising strategy.However,this strategy not only hinges on the sophisticated design of nanomaterials to enhance drug bioavailability but also requires the functionality to precisely activate immunity with missile-like specificity.Recent investigations into the mechanistic basis and translational applications of nanomaterial-based cancer immunotherapy alongside multifunctional therapeutic strategies have witnessed a continuous upsurge in high-impact scholarly outputs.On the basis of these researches,this review comprehensively summarizes the categories of nanomaterials for enhancing antitumor immune responses,discusses their physicochemical properties influencing tumors and tumor-draining lymph nodes targeting capacity,and highlights recent advances in the design of multifunctional nanoplatforms to improve the efficacy of cancer immunotherapy.Finally,challenges associated with the development of next-generation nanomaterials are further discussed to facilitate their advances and clinical translation.
Bo Shi;Pengfei Ni;Lelei Xiao;Wenpei Fan
State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases,Center of Advanced Pharmaceuticals and Biomaterials,China Pharmaceutical University,Nanjing 211198,ChinaState Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases,Center of Advanced Pharmaceuticals and Biomaterials,China Pharmaceutical University,Nanjing 211198,ChinaState Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases,Center of Advanced Pharmaceuticals and Biomaterials,China Pharmaceutical University,Nanjing 211198,ChinaState Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases,Center of Advanced Pharmaceuticals and Biomaterials,China Pharmaceutical University,Nanjing 211198,China
通用工业技术
NanomaterialsCancer immunotherapyMultifunctional nanomaterialsImmunogenic cell deathTumor microenvironment
《Nano Biomedicine & Engineering》 2026 (1)
P.58-65,8
financially supported by the National Innovation and Entrepreneurship Training Program for Undergraduate(No.202510316072Z)
评论